Latest / JACC Specialty Journals
JACC: CardioOncology - Oncotherapeutic Protein Kinase Inhibitors Associated with Pro-Arrhythmic Liability
Commentary by Dr. Richard Kovacs
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.